Self-Assembled Core–Shell Nanoscale Coordination Polymer Nanoparticles Carrying a Sialyltransferase Inhibitor for Cancer Metastasis Inhibition
Source abstract
Abstract
Despite hypersialylation of cancer cells together with a significant upregulation of sialyltransferase (ST) activity contributes to the metastatic cascade at multiple levels, there are few dedicated tools to interfere with their expression. Although transition state-based ST inhibitors are well-established, they are not membrane permeable. To tackle this problem, herein, we design and construct long-circulating, self-assembled core-shell nanoscale coordination polymer (NCP) nanoparticles carrying a transition state-based ST inhibitor, which make the inhibitor transmembrane and potently strip diverse sialoglycans from various cancer cells. In the experimental lung metastasis and metastasis prevention models, the nanoparticle device (NCP/STI) significantly inhibits metastases formation without systemic toxicity. This strategy enables ST inhibitors to be applied to cells and animals by providing them with a well-designed nanodelivery system. Our work opens a new avenue to the development of transition state-based ST inhibitors and demonstrates that NCP/STI holds great promise in achieving metastases inhibition for multiple cancers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Glycosylation and Glycoproteins Research · Cancer Research and Treatments · Bone and Dental Protein Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, and Chemical Biology Center, Peking University, Beijing 100191, China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China
References (56)
Show source-provided references
1. 10.3322/caac.2155110.3322/caac.21551 ↗
2. 10.1038/nrclinonc.2010.17110.1038/nrclinonc.2010.171 ↗
3. 10.1001/jamaoncol.2015.251010.1001/jamaoncol.2015.2510 ↗
4. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
5. 10.1007/s10555-012-9359-710.1007/s10555-012-9359-7 ↗
6. 10.1158/0008-5472.CAN-14-072810.1158/0008-5472.CAN-14-0728 ↗
7. 10.1093/glycob/cwq18910.1093/glycob/cwq189 ↗
8. 10.1016/j.ejphar.2018.11.01410.1016/j.ejphar.2018.11.014 ↗
9. 10.1038/onc.2008.47110.1038/onc.2008.471 ↗
10. 10.1002/med.2140710.1002/med.21407 ↗
11. 10.1006/bbrc.2001.500210.1006/bbrc.2001.5002 ↗
12. 10.1016/j.ejmech.2011.05.04910.1016/j.ejmech.2011.05.049 ↗
13. 10.1002/jcp.2206810.1002/jcp.22068 ↗
14. 10.1021/acs.jmedchem.0c0147710.1021/acs.jmedchem.0c01477 ↗
15. 10.1038/nchembio.99910.1038/nchembio.999 ↗
16. 10.1074/jbc.M114.60651710.1074/jbc.M114.606517 ↗
17. 10.1002/(SICI)1521-3773(19981102)37:20<2893::AID-ANIE2893>3.0.CO;2-W10.1002/(SICI)1521-3773(19981102)37:20<2893::AID-ANIE2893>3.0.CO;2-W ↗
18. 10.1021/ja017370n10.1021/ja017370n ↗
19. 10.1038/s41598-017-14560-010.1038/s41598-017-14560-0 ↗
20. 10.1021/acs.jmedchem.5b0118110.1021/acs.jmedchem.5b01181 ↗
21. 10.1021/acs.jmedchem.6b0164410.1021/acs.jmedchem.6b01644 ↗
22. 10.1146/annurev-med-040210-16254410.1146/annurev-med-040210-162544 ↗
23. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
24. 10.1016/j.addr.2020.05.00510.1016/j.addr.2020.05.005 ↗
25. 10.1021/acs.biomac.1c0135610.1021/acs.biomac.1c01356 ↗
26. 10.1021/nn202410f10.1021/nn202410f ↗
27. 10.1002/mco2.810.1002/mco2.8 ↗
28. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
29. 10.1016/j.biomaterials.2019.04.02810.1016/j.biomaterials.2019.04.028 ↗
30. 10.1016/j.ccr.2019.21303910.1016/j.ccr.2019.213039 ↗
31. 10.1016/S0968-0896(03)00489-910.1016/S0968-0896(03)00489-9 ↗
32. 10.1002/med.1003010.1002/med.10030 ↗
33. 10.5246/jcps.2020.01.00310.5246/jcps.2020.01.003 ↗
34. 10.1038/ncomms518210.1038/ncomms5182 ↗
35. 10.1016/j.jconrel.2011.10.02010.1016/j.jconrel.2011.10.020 ↗
36. 10.1039/c2cc17635a10.1039/c2cc17635a ↗
37. 10.1016/j.biomaterials.2015.12.01810.1016/j.biomaterials.2015.12.018 ↗
38. 10.1126/science.284.5418.137210.1126/science.284.5418.1372 ↗
39. 10.1016/j.mrrev.2012.08.00110.1016/j.mrrev.2012.08.001 ↗
40. 10.1016/j.biomaterials.2013.12.03010.1016/j.biomaterials.2013.12.030 ↗
41. 10.1126/sciadv.aav996010.1126/sciadv.aav9960 ↗
42. 10.1016/j.biomaterials.2020.12058210.1016/j.biomaterials.2020.120582 ↗
43. 10.1074/mcp.M112.01755810.1074/mcp.M112.017558 ↗
44. 10.1016/j.cell.2011.09.02410.1016/j.cell.2011.09.024 ↗
45. 10.1158/0008-5472.CAN-10-130310.1158/0008-5472.CAN-10-1303 ↗
46. 10.1158/1078-0432.CCR-04-111010.1158/1078-0432.CCR-04-1110 ↗
47. 10.1021/nn506196410.1021/nn5061964 ↗
48. 10.1002/smll.20120139010.1002/smll.201201390 ↗
49. 10.1016/j.nano.2012.08.00510.1016/j.nano.2012.08.005 ↗
50. 10.1074/jbc.M117.80858410.1074/jbc.M117.808584 ↗
51. 10.1074/jbc.RA120.01412610.1074/jbc.RA120.014126 ↗
52. 10.1016/j.jbc.2022.10172610.1016/j.jbc.2022.101726 ↗
53. 10.1016/j.jaci.2013.05.01810.1016/j.jaci.2013.05.018 ↗
54. 10.1016/j.molimm.2012.11.00610.1016/j.molimm.2012.11.006 ↗
55. 10.1016/j.exppara.2013.08.00910.1016/j.exppara.2013.08.009 ↗
56. 10.1016/j.ejphar.2013.07.01910.1016/j.ejphar.2013.07.019 ↗